Biologics Contract Manufacturing Market to grow from $28.9 BN to $57.9 BN by 2034 at 7.2% CAGR. Key Players: Samsung Biologics, Lonza, WuXi Biologics.
Biologics Contract Manufacturing Market is projected to grow significantly from USD 28.9 billion in 2024 to USD 57.9 billion by 2034, expanding at a CAGR …